MEPHENYTOIN AND SPARTEINE OXIDATION - GENETIC POLYMORPHISMS IN DENMARK

被引：44

作者：

DROHSE, A ^{[1
]}

BATHUM, L ^{[1
]}

BROSEN, K ^{[1
]}

GRAM, LF ^{[1
]}

机构：

[1] ODENSE UNIV,DEPT CLIN PHARMACOL,JB WINSLOWS VEJ 19,DK-5000 ODENSE C,DENMARK

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 27卷 / 05期

关键词：

D O I：

10.1111/j.1365-2125.1989.tb03426.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：620 / 625

页数：6

共 19 条

[1]

BERTILSSON L, 1989, IN PRESS CLIN PHARM

[2]

BREIMER DA, 1988, 7TH P INT S MICR DRU, P232

[3]

BROSEN K, 1985, ACTA PHARMACOL TOX, V57, P357

[4] GENETICALLY-DETERMINED VARIABILITY IN ACETYLATION AND OXIDATION - THERAPEUTIC IMPLICATIONS [J].

CLARK, DWJ .

DRUGS, 1985, 29 (04) :342-375

[5] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].

EICHELBAUM, M ;

SPANNBRUCKER, N ;

STEINCKE, B ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187

[6] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[7] CHARACTERIZATION OF THE COMMON GENETIC-DEFECT IN HUMANS DEFICIENT IN DEBRISOQUINE METABOLISM [J].

GONZALEZ, FJ ;

SKODA, RC ;

KIMURA, S ;

UMENO, M ;

ZANGER, UM ;

NEBERT, DW ;

GELBOIN, HV ;

HARDWICK, JP ;

MEYER, UA .

NATURE, 1988, 331 (6155) :442-446

[8] MEPHENYTOIN AND SPARTEINE PHARMACOGENETICS IN CANADIAN CAUCASIANS [J].

INABA, T ;

JURIMA, M ;

NAKANO, M ;

KALOW, W .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 36 (05) :670-676

[9]

INABA T, 1986, AM J HUM GENET, V38, P768

[10] GENETIC-POLYMORPHISM OF MEPHENYTOIN P(4')-HYDROXYLATION - DIFFERENCE BETWEEN ORIENTALS AND CAUCASIANS [J].

JURIMA, M ;

INABA, T ;

KADAR, D ;

KALOW, W .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1985, 19 (04) :483-487

← 1 2 →